계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Inhalon Biopharma
company
About
Inhalon Biopharma is a bio-tech company which is into research & development of monoclonal antibodies.
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $7M
- Industries
- Biopharma,Biotechnology
- Founded date
- Oct 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Inhalon Biopharma is into developing monoclonal antibodies (mAb) using technology that enables trapping of pathogens in mucus secretions for treating diseases of the respiratory tract.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$7M
Inhalon Biopharma has raised a total of
$7M
in funding over 2 rounds. Their latest funding was raised on
May 26, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 26, 2021 | Grant | $7M | 1 |
U.S. Army Medical Research & Development Command
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Inhalon Biopharma is funded by 1 investors.
U.S. Army Medical Research & Development Command
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
U.S. Army Medical Research & Development Command
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
